Literature DB >> 24759379

Surveillance for hepatocellular carcinoma: evidence, guidelines and utilization.

Mohamed G Shoreibah1, Joseph R Bloomer, Brendan M McGuire, Omar I Massoud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24759379     DOI： 10.1097/MAJ.0000000000000200

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  4 in total

1.  Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.

Authors:  Haijian Zhang; Min Yao; Wei Wu; Liwei Qiu; Wenli Sai; Junling Yang; Wenjie Zheng; Jianfei Huang; Dengfu Yao
Journal:  Tumour Biol       Date:  2015-06-26

2.  Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Authors:  Maria E Lozada; Roongruedee Chaiteerakij; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2015-06

Review 3.  Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.

Authors:  Jeong Hee Yoon; Joong-Won Park; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

4.  Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma.

Authors:  Yu Wang; Weixin Yu; Mingqing He; Yan Huang; Mingyue Wang; Jinzhou Zhu
Journal:  Onco Targets Ther       Date:  2018-12-31       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.